Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

This study has been completed.
Information provided by (Responsible Party):
Linda R Duska, University of Virginia Identifier:
First received: November 14, 2011
Last updated: May 11, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)